commission com(1998) 588 on single market for pharmaceutical products
Post on 10-Apr-2018
217 Views
Preview:
TRANSCRIPT
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
1/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
2/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
3/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
4/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
5/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
6/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
7/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
8/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
9/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
10/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
11/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
12/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
13/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
14/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
15/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
16/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
17/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
18/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
19/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
20/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
21/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
22/36
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
23/36
21.
$QQH[
.H\ILJXUHV(XURSHDQ8QLRQ$SSOLFDQWFRXQWULHV2(&'
3RSXODWLRQPLOOLRQ
7RWDO*'3ELOOLRQ
*'3SHUFDSLWD
3KDUPDFHXWLFDOPDUNHWELOOLRQ
%HOJLXP 10 228 22,546 2,70
'HQPDUN 5 173 33,185 1,10
*HUPDQ\ 81 1,835 22,539 21,80
*UHHFH 11 100 9,576 1,20
6SDLQ 39 559 14,264 7,60
)UDQFH 58 1,538 26,462 25,30
,UHODQG 4 52 14,576 0,40
,WDO\ 58 1,018 17,797 12,10
/X[HPERXUJ 0,5 11 27,053 0,10
1HWKHUODQGV 15 395 25,591 4,20
$XVWULD 8 233 28,844 2,10
3RUWXJDO 10 83 8,368 1,30
)LQODQG 5 126 24,651 1,00
6ZHGHQ 9 229 25,779 2,80
8QLWHG.LQJGRP 59 1,104 18,848 8,40
%XOJDULD 8 10 1,127 0,20
&]HFK5HSXEOLF 10 46 4,402 1,00
(VWRQLD 2 2 1,132 0,03
+XQJDU\ 10 41 4,033 0,60
/DWYLD 3 4 1,767 0,05
/LWKXDQLD 4 6 1,495 0,10
3RODQG 39 93 2,402 1,40
5RPDQLD 23 30 1,324 0,20
6ORYDN5HSXEOLF 5 17 3,220 0,10
6ORYHQLD 2 14 7,024 0,10
8QLWHG6WDWHV 263 7,246 27,538 84,00
-DSDQ 125 4,591 36,739 53,20
6ZLW]HUODQG 7 304 42,989 2,90
Source : EPISCOM Data
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
24/36
22.
$QQH[
+HDOWKH[SHQGLWXUHDQGSKDUPDFHXWLFDOH[SHQGLWXUHDVRI*'3
+HDOWKH[SHQGLWXUHRI*'3
3KDUPDFHXWLFDOH[SHQGLWXUHRI*'3
3KDUPDFHXWLFDOH[SHQGLWXUH
KHDOWKH[S
3KDUPDFHXWLFDOH[SHQGLWXUH
SHUFDSLWD
%HOJLXP 7,6 % 1,4 % 13 % 267
'HQPDUN 7,7 % 0,7 % 12 % 215
*HUPDQ\ 10,4 % 1,3 % 11 % 269
*UHHFH 7,1 % 1,8 % 25 % 118
6SDLQ 7,4 % 1,5 % 16 % 193
)UDQFH 9,9 % 1,7 % 17 % 435
,UHODQG 7,0 % 0,7 % 10 % 111
,WDO\ 7,6 % 1,4 % 14 % 209
/X[HPERXUJ 7,1 % 0,8 % 12 % 260
1HWKHUODQGV 8,5 % 0,9 % 13 % 272
$XVWULD 7,9 % 1,1 % 10 % 260
3RUWXJDO 8,2 % 2,2 % 18 % 127
)LQODQG 7,3 % 1,1 % 11 % 192
6ZHGHQ 8,6 % 1,1 % 16 % 315
8QLWHG.LQJGRP 6,7 % 1,2 % 10 % 143
%XOJDULD n.a. n.a. 35 % 25
&]HFK5HSXEOLF n.a. n.a. 28 % 94
(VWRQLD n.a. n.a. 28 % 20
+XQJDU\ n.a. n.a. 30 % 63
/DWYLD n.a. n.a. 29 % 19
/LWKXDQLD n.a. n.a. 25 % 19
3RODQG n.a. n.a. 19 % 36
5RPDQLD n.a. n.a. 23 % 10
6ORYDN5HSXEOLF n.a. n.a. 17 % 23
6ORYHQLD n.a. n.a. 13 % 52
8QLWHG6WDWHV 14,0 % 1,1 % 7 % 319
-DSDQ n.a. n.a. 20 % 425
6ZLW]HUODQG 10,2 % 0,8 % 11 % 396
Data : 1997 - Source : OECD Health Data 98 + EPISCOM Data
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
25/36
23.
$QQH[
7RWDODQGSXEOLFH[SHQGLWXUHRQKHDOWKDQGRQSKDUPDFHXWLFDOV
7RWDOH[SHQGLWXUH
RQKHDOWK
3XEOLFH[SHQGLWXUH
RQKHDOWK
7RWDOH[SHQGLWXUH
RQKDUPDFHXWLFDOV
3XEOLFH[SHQGLWXUH
RQSKDUPDFHXWLFDOV
%HOJLXP 16 412 14 397 2 942 1 338
'HQPDUN 10 953 7 142 1 003 507
*HUPDQ\ 195 335 152 912 24 822 18 010
*UHHFH 6 546 5 073 1 740 290
6SDLQ 33 891 26 686 6 791 5 055
)UDQFH 117 334 94 630 19 931 12 222
,UHODQG 3 924 2 911 389 304
,WDO\ 74 875 52 293 13 416 5 405
/X[HPERXUJ 903 835 106 85
1HWKHUODQGV 26 904 19 385 2 945 1 882
$XVWULD 14 349 10 329 2 028 1 196
3RUWXJDO 6 743 4 036 1 773 1 120
)LQODQG 7 304 5 727 1 107 515
6ZHGHQ 17 107 14 194 2 230 1 588
8QLWHG.LQJGRP 63 078 53 332 10 432 6 599
(XURSHDQ8QLRQ
8QLWHG6WDWHV 815 024 380 376 72 002 10 479
-DSDQ 261 323 205 737 54 353 35 849
6ZLW]HUODQG 23 529 16 465 1 791 1 094
1996 data in Million ECU
Source : OECD Health Data 98
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
26/36
24.
$QQH[
3KDUPDFHXWLFDOSURGXFWLRQLPSRUWVH[SRUWVDQGWUDGHEDODQFH
3URGXFWLRQ
(&8PLOOLRQ
,PSRUWV
(&8PLOOLRQ
([SRUWV
(&8PLOOLRQ
7UDGHEDODQFH
(&8PLOOLRQV
%HOJLXP 3 595 3 127 4 241 1 114
'HQPDUN 2 004 748 2 105 1 357
*HUPDQ\ 17 449 6 150 10 187 4 037
*UHHFH 470 561 65 - 496
6SDLQ 5 996 2 378 1 355 - 1 023
)UDQFH 20 113 4 931 5 838 907
,UHODQG 2 301 585 2 201 1 616
,WDO\ 11 505 5 441 753 8 908
/X[HPERXUJ n.a. n.a. n.a. n.a.
1HWKHUODQGV 3 664 3 095 3 292 197
$XVWULD 1 086 1 688 1 356 - 332
3RUWXJDO 418 568 133 - 435
)LQODQG 566 541 189 - 352
6ZHGHQ 3 637 1 086 2 657 1 571
8QLWHG.LQJGRP 15 111 3 821 6 585 2 764
(XURSHDQ8QLRQ
8QLWHG6WDWHV 3 997 5 121 1 124
-DSDQ 50 142 3 834 1 500 - 2 334
6ZLW]HUODQG 10 706 3 881 10 194 6 313
1996 data in Million ECU
Source : OECD Health Data 98
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
27/36
25.
$QQH[
(YROXWLRQRISURGXFWLRQLQWKHSKDUPDFHXWLFDOLQGXVWU\
Figures : billion ECU, current prices
Source : Eurostat
-DSDQ
86$
(8
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
28/36
26.
$QQH[
(XURSHDQ8QLRQWUDGHEDODQFHLQSKDUPDFHXWLFDOV
([SRUWVIURPWKH
(XURSHDQ8QLRQ
,PSRUWVLQWRWKH
(XURSHDQ8QLRQ
7UDGHEDODQFHRIWKH
(XURSHDQ8QLRQ
8QLWHG6WDWHV 3,226 3,394 - 168
6ZLW]HUODQG 2,181 4,028 - 1,847
-DSDQ 1,627 666 961
$XVWUDOLD 660 101 559
&DQDGD 496 96 400
1RUZD\ 390 123 267
&KLQD 289 306 - 17
&((& 1,521 169 1,352
&,6 574 6 568
0HGLWHUUDQHDQ%DVLQ 1,583 114 1,469
/DWLQ$PHULFD 1,292 128 1,16423(& 1,210 13 1,197
2WKHUV 3,676 446 3,230
7RWDO 18,725 9,590 9,135
GDWDLQ(&8PLOOLRQV
6RXUFH(XURVWDW6,7&5HY
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
29/36
27.
$QQH[
(YROXWLRQRI(XURSHDQ8QLRQWUDGHEDODQFHLQSKDUPDFHXWLFDOV
Figures : million ECUSource : EFPIA member associations
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
30/36
28.
$QQH[
3KDUPDFHXWLFDOHPSOR\PHQWDQG5'LQYHVWPHQW
7RWDOHPSOR\PHQW
XQLWV
(PSOR\PHQWLQUHVHDUFK
XQLWV
,QYHVWPHQWLQUHVHDUFK
(&8PLOOLRQ
0DUNHWYDOXHDWH[IDFWRU\SULFHV
(&8PLOOLRQ
%HOJLXP 20 117 1 996 413 2 197
'HQPDUN 15 672 4 045 361 811
*HUPDQ\ 115 500 14 826 2 700 15 735
*UHHFH 7 800 n.a. n.a. 1 027
6SDLQ 38 500 2 320 260 5 305
)UDQFH 87 600 14 900 2 150 13 875
,UHODQG 10 900 n.a. n.a. 362
,WDO\ 64 119 5 441 753 8 908
/X[HPERXUJ n.a. n.a. n.a. n.a.
1HWKHUODQGV 13 500 2 250 260 1 908
$XVWULD 9 260 n.a. n.a. 1 196
3RUWXJDO 9 000 n.a. n.a. 1 429
)LQODQG 5 606 1 173 81 1 118
6ZHGHQ 16 000 5 300 1 052 1 814
8QLWHG.LQJGRP 74 000 19 000 2 553 6 425
(XURSHDQ8QLRQ
8QLWHG6WDWHV 203 009 49 409 13 314 58 255
-DSDQ 160 300 30 700 5 221 47 164
6ZLW]HUODQG 26 700 16 465 1 791 1 094
1997 data, except : Ireland, Portugal and UK (1996) and Japan (1995)
Source : EFPIA, PhRMA, JPMA
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
31/36
29.
$QQH[
(YROXWLRQRIHPSOR\PHQWLQWKHSKDUPDFHXWLFDOVHFWRU
Figures : thousand unitsSource : Eurostat (Japan, USA), EFPIA (EU-15)
-DSDQ
86$
(8
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
32/36
30.
$QQH[
,QSDWHQWDQGRXWRISDWHQWSURGXFWVRIUHLPEXUVDEOHSDFNV
,QSDWHQWSURGXFWV
2XWRISDWHQWSURGXFWV
PXOWLVRXUFH
2XWRISDWHQWSURGXFWV
VLQJOHVRXUFH
1RQSUHVFULSWLRQUHLPEXUVDEOH
SURGXFWV
%HOJLXP 16 % 34 % 49 % 0 %
'HQPDUN 10 % 54 % 24 % 12 %
*HUPDQ\ 5 % 40 % 22 % 33 %
*UHHFH 9 % 48 % 30 % 13 %
6SDLQ 15 % 36 % 36 % 13 %
)UDQFH 8 % 30 % 56 % 6 %
,UHODQG n.a. n.a. n.a. n.a.
,WDO\ 31 % 43 % 25 % 1 %
/X[HPERXUJ n.a. n.a. n.a. n.a.
1HWKHUODQGV 16 % 58 % 18 % 8 %
$XVWULD 13 % 34 % 49 % 4 %
3RUWXJDO 3 % 50 % 47 % 0 %
)LQODQG 11 % 49 % 40 % 0 %
6ZHGHQ n.a. n.a. n.a. n.a.
8QLWHG.LQJGRP 11 % 46 % 28 % 15 %
(XURSHDQ8QLRQ
Source : Merck & Co, Inc. analysis of 1996 IMS data
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
33/36
31.
$QQH[
6HOIPHGLFDWLRQDQGQRQSUHVFULSWLRQSKDUPDFHXWLFDOV
,QKDELWDQWVSHUSKDUPDF\
6HOIPHGLFDWLRQPDUNHWVKDUH
1RQSUHVFULSWLRQPDUNHWVKDUH
9$7UDWHRQQRQSUHVFULSWLRQ
PHGLFLQHV
%HOJLXP 1,922 17,6 % 19,8 % 6,0 %
'HQPDUN 17,966 16,0 % 16,0 % 25,0 %
*HUPDQ\ 3,890 17,7 % 32,1 % 16,0 %
*UHHFH 1,450 n.a. n.a. 8,0 %
6SDLQ 2,150 12,7 % 15,5 % 4,0 %
)UDQFH 2,560 10,9 % 32,2 % 5,5 %
,UHODQG 3,080 20,0 % 21,0 % 21,0 %
,WDO\ 3,460 8,2 % 13,9 % 10,0 %
/X[HPERXUJ 5,063 n.a. n.a. 5,0 %
1HWKHUODQGV 10,400 9,0 % 12,5 % 6,0 %
$XVWULD 4,036 9,5 % 11,2 % 20,0 %
3RUWXJDO 4,250 10,8 % 10,8 % 5,0 %
)LQODQG 6,482 14,9 % 14,9 % 12,0 %
6ZHGHQ 9,780 9,4 % 10,3 % 25,0 %
8QLWHG.LQJGRP 4,730 20,1 % 24,0 % 17,5 %
%XOJDULD 3,283 n.a. n.a. 22,0 %
&]HFK5HSXEOLF 6,435 16,0 % 16,0 % 5,0 %
+XQJDU\ 5,073 16,2 % 16,2 % 0,0 %
5RPDQLD 5,630 27,0 % 27,0 % 11,0 %
6ORYDN5HSXEOLF 5,250 17,8 % 21,0 % 6,0 %
6ORYHQLD n.a. 12,0 % 12,0 % 5,0 %
1997 dataSource : AESGP Facts and Figures, 1998
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
34/36
32.
$QQH[
3ULFHVWUXFWXUH:KROHVDOHUDQG3KDUPDFLVWPDUJLQV
as % of Retail price (VAT excluded)
Source : GIRP European Pharmaceutical Data 1997 (except : Ireland)
United Kingdom
Sweden
Finland
Portugal
Austria
Netherlands
Luxembourg
Italy
Ireland
France
Spain
Greece
Germany
Denmark
Belgium
([IDFWRU\
:KROHVDOHU
3KDUPDFLVW
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
35/36
33.
$QQH[
3DUDOOHOLPSRUWVDVRIWRWDOPDUNHW
Source : GIRP European Pharmaceutical Data 1997 (IMS )
United Kingdom
Sweden
Finland
Netherlands
Germany
Denmark
Belgium
-
8/8/2019 Commission COM(1998) 588 on Single Market for Pharmaceutical Products
36/36
$QQH[
3KDUPDFHXWLFDOVDOHVRSHUDWLQJSURILWV5'VSHQG7RSILUPVLQ
6DOHVPLOOLRQ
2SHUDWLQJ3URILW
PLOOLRQ
0DUJLQ
5'VSHQG
PLOOLRQ
5'VDOHV
Merck & Co 18,475 5,541 27,9 1,487 7,5
Glaxo-Wellcome 14,284 5364 37,5 1,988 13,9
Novartis 9,110 2,911 24,0 1,711 18,8
Bristol-Myers Squibb 8,702 2,871 33,0 1,276 14,7
Hoechst Marion Roussel 8,455 1,461 17,3 1,453 17,2
Pfizer 8,188 3,090 32,1 1,522 15,8
SmithKline Beecham 8,148 2,019 24,8 1,204 14,8
American Home Products 7,924 2,770 24,5 1,100 13,9
Roche 7,808 n.a. n.a. 1,574 20,2
Rhone-Poulenc 7,686 932 12,1 1,100 14,3
Bayer Group 7,679 1,214 15,8 1,127 14,7
Johnson & Jonhson 7,188 2,477 34,5 1,093 15,2
Pharmacia & Upjohn 7,176 1,420 19,8 1,266 17,6
Eli Lilly 6,799 2 ,031 27,6 1,190 16,2
Abbott Laboratories 6,307 1,898 30,1 - -
Astra 5,657 1,773 31,3 1,024 18,1
Schering-Plough 5,050 1,606 28,4 733 13,0
Takeda 4,573 965 21,1 580 8,6
Corange 4,226 561 13,3 566 13,4
Zeneca 4,170 1,296 31,1 668 16,0
Source : Chemical Insight, Late December 1997
top related